A recent study found that radioresistant lung adenocarcinoma cells were less sensitive to pemetrexed treatment after long-term fractionated radiotherapy, and the authors argued that this was due to the significant downregulation of folate receptor alpha (FRα), which caused a decreased drug uptake into the cell [88]. The gene discussed is FOLR1; the disease is lung adenocarcinoma.